Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
104
Frequently Asked Questions
What is Market Cap of Niagen Bioscience Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Niagen Bioscience Inc. market cap is $750.48M.
What is the 52-week high for Niagen Bioscience Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Niagen Bioscience Inc. 52 week high is $14.69 as of September 06, 2025.
What is the 52-week low for Niagen Bioscience Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Niagen Bioscience Inc. 52 week low is $3.16 as of September 06, 2025.
What is Niagen Bioscience Inc. stock price today?
Niagen Bioscience Inc. stock price today is $9.41.
What was Niagen Bioscience Inc. stock price yesterday?
Niagen Bioscience Inc. stock price yesterday was $9.32.
What is the PE ratio of Niagen Bioscience Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Niagen Bioscience Inc.’s P/E ratio is 43.83.
What is the Price-to-Book ratio of Niagen Bioscience Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Niagen Bioscience Inc. P/B ratio is 11.6661.
What is the 50-day moving average of Niagen Bioscience Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Niagen Bioscience Inc. 50-day moving average is $10.48.
How many employess does Niagen Bioscience Inc. has?